Pedro Huertas
2020 - Inozyme Pharma
In 2020, Pedro Huertas earned a total compensation of $1.2M as Senior Vice President and Chief Medical Officer at Inozyme Pharma.
Compensation breakdown
| Non-Equity Incentive Plan | $159,137 |
|---|---|
| Option Awards | $604,993 |
| Salary | $397,843 |
| Total | $1,161,973 |
Huertas received $605K in option awards, accounting for 52% of the total pay in 2020.
Huertas also received $159.1K in non-equity incentive plan and $397.8K in salary.
Rankings
In 2020, Pedro Huertas' compensation ranked 7,996th out of 13,090 executives tracked by ExecPay. In other words, Huertas earned more than 38.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,996 out of 13,090 | 39th |
Division Manufacturing | 3,392 out of 5,621 | 40th |
Major group Chemicals And Allied Products | 1,372 out of 2,254 | 39th |
Industry group Drugs | 1,194 out of 1,954 | 39th |
Industry Pharmaceutical Preparations | 887 out of 1,459 | 39th |
Source: SEC filing on April 27, 2021.
Huertas' colleagues
We found two more compensation records of executives who worked with Pedro Huertas at Inozyme Pharma in 2020.